This compound is a chemical intermediate used in the synthesis of alogliptin benzoate impurities. It features a pyrimidinedione ring with chloro, ethyl, and benzonitrile substituents.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1430222-06-2
Alogliptin Impurity 07
Pharmaceutical impurity reference standard
2-((6-Chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
pharmaceutical intermediate
2-[[6-[(3R)-3-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile
Impurity of alogliptin
1alpha-Hydroxy VD4
Vitamin D analog intermediate
(2R,3S,4S)-2,3,4-Tris(benzyloxy)-4-(4-((benzyloxy)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-(4-methylpiperazin-1-yl)butan-1-one oxalate
pharmaceutical intermediate synthesis
Ethyl 2-(2-benzyl-3-hydroxypropanamido)acetate
pharmaceutical intermediate for alvimopan impurities
2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-benzonitrile-d3
pharmaceutical impurity reference standard
2-((6-Chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
research compound
2-[(6-chloro-3-ethyl-2,4-dioxopyrimidin-1-yl)methyl]benzonitrile
OLHHKMKGYKDSCX-UHFFFAOYSA-N
CCN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)Cl